Pascal Biosciences: Funding, Investors & Team (Oct 2026)
Pascal Biosciences Inc. (PAS, formerly, bioMmune Technologies Inc.) is a biotechnology company engaged in developing breakthrough treatments in the field of immuno-oncology. Their strategy aims to leverage their innovative technologies and experienced leadership and scientific team to develop new, effective therapeutics that will change the lives of patients. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol “PAS”.
Pascal Biosciences has raised $300k across 1 funding round on record, the most recent an undisclosed round of $300k announced in Jun 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pascal Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Pascal Biosciences Funding Rounds
Pascal Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Pascal Biosciences Funding Compared to Other Biotechnology Startups
Pascal Biosciences' latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pascal Biosciences in Biotechnology and Seattle
Companies Similar to Pascal Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Pascal Biosciences Funding FAQs
What does Pascal Biosciences do?
Pascal Biosciences Inc. (PAS, formerly, bioMmune Technologies Inc.) is a biotechnology company engaged in developing breakthrough treatments in the field of immuno-oncology. Their strategy aims to leverage their innovative technologies and experienced leadership and scientific team to develop new, effective therapeutics that will change the lives of patients. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol “PAS”.
How much funding has Pascal Biosciences raised?
Pascal Biosciences has raised $300k across 1 round on record. The most recent is an undisclosed round of $300k announced in Jun 2021.
When did Pascal Biosciences last raise funding?
Pascal Biosciences' most recent funding round on record is an undisclosed round of $300k, announced in Jun 2021.
Who is the CEO of Pascal Biosciences?
Patrick Gray is listed as CEO at Pascal Biosciences.
Where is Pascal Biosciences headquartered?
Pascal Biosciences is based in Seattle, Washington, United States.
How many employees does Pascal Biosciences have?
Pascal Biosciences is in the 51-100 employee band.
How does Pascal Biosciences' funding compare to other Biotechnology startups?
Pascal Biosciences' latest round of $300k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Pascal Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pascal Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.